Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.10
-0.39-7.10%
At close: -
$5.57
0.479.22%
After Hours: 8:13 AM EDT
Comments
Loading...
Avalo Therapeutics (AVTX) Forecast
NewsEarningsAvalo Therapeutics (AVTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Avalo Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:AVTX | Benzinga
Explore Avalo Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AVTX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Avalo Therapeutics (AVTX) stock?
You can purchase shares of Avalo Therapeutics (NASDAQ:AVTX) through any online brokerage.
Who are Avalo Therapeutics (AVTX) competitors?
Other companies in Avalo Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Cabaletta Bio (NASDAQ:CABA), Inozyme Pharma (NASDAQ:INZY) and Inovio Pharmaceuticals (NASDAQ:INO).
What is the forecast, or price target, for Avalo Therapeutics (AVTX) stock?
Avalo Therapeutics has a consensus price target of $26.22.
What is the current price for Avalo Therapeutics (AVTX)?
The stock price for Avalo Therapeutics (NASDAQ: AVTX) is $5.57 last updated April 9, 2025 at 8:13 AM EDT.
Does Avalo Therapeutics (AVTX) pay a dividend?
There are no upcoming dividends for Avalo Therapeutics.
When is Avalo Therapeutics (NASDAQ:AVTX) reporting earnings?
Avalo Therapeutics’s Q1 earnings are confirmed for Monday, May 12, 2025.
Is Avalo Therapeutics (AVTX) going to split?
There is no upcoming split for Avalo Therapeutics.
What sector and industry does Avalo Therapeutics (AVTX) operate in?
Avalo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.